13F HOLDINGS REPORT
Checkpoint Capital L.P.
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001977548-25-000004
Total Value
$196.5M
Positions
16
Other Managers
0
Confidential Omitted
No
Holdings (16)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | ARGENX SE | ARGX | 92,500 | $56.9M | 28.95% |
| 2 | RHYTHM PHARMACEUTICALS INC | RYTM | 727,982 | $40.8M | 20.74% |
| 3 | PHATHOM PHARMACEUTICALS INC | PHAT | 2,274,157 | $18.5M | 9.40% |
| 4 | AXSOME THERAPEUTICS INC | AXSM | 174,769 | $14.8M | 7.53% |
| 5 | DISC MEDICINE INC | IRON | 185,000 | $11.7M | 5.97% |
| 6 | AVADEL PHARMACEUTICALS PLC | G29687103 | 1,004,790 | $10.6M | 5.37% |
| 7 | REVOLUTION MEDICINES INC | RVMDW | 210,000 | $9.2M | 4.67% |
| 8 | PLIANT THERAPEUTICS INC | PLRX | 535,494 | $7.1M | 3.59% |
| 9 | TSCAN THERAPEUTICS INC | TCRX | 1,755,987 | $5.3M | 2.72% |
| 10 | CIDARA THERAPEUTICS INC | 171757206 | 196,949 | $5.1M | 2.60% |
| 11 | TREVI THERAPEUTICS INC | TRVI | 1,084,135 | $4.5M | 2.27% |
| 12 | STOKE THERAPEUTICS INC | STOK | 305,387 | $3.4M | 1.71% |
| 13 | SOLENO THERAPEUTICS INC | SLNO | 70,027 | $3.1M | 1.60% |
| 14 | KYMERA THERAPEUTICS INC | KYMR | 77,535 | $3.1M | 1.59% |
| 15 | ATYR PHARMA INC | ATYR | 432,561 | $1.6M | 0.80% |
| 16 | CYTOKINETICS INC | CYTK | 20,000 | $940,800 | 0.48% |